ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

• Rely On ePRO And EDC For Easier Cleaner Data

  What makes a clinical trials software provider a good fit? How do you make the decision to use a particular electronic data capture (EDC) system or electronic patient reported outcome (ePRO) solution? Learn how the answers are different for every sponsor and contract research organization (CRO).

• FDA Releases Updated Draft Guidance On Decentralized Clinical Trials

  Take a closer look at the FDA's draft guidance on designing and implementing DCTs, notably remote trial visits, the use of digital health technologies, institutional review board oversight, and more.

• 3 Proven eConsent Implementation And Adoption Best Practices

  By advocating these three essential best practices, learn how stakeholders can navigate the complexities of eConsent adoption with confidence and enhance the overall efficiency and success of clinical trials.

• The Pharmaceutical Industry: 2024 (And Beyond) Predictions

  DCTs, RWD, IRA … our industry predictions for 2024 are filled with acronyms. As we delve into 2024, explore what trends are hot ― and not ― for the coming year, and their impact on the industry.

• Common RTSM/IRT AN Medication Pooling Questions Answered

  Whether you’re planning a single trial or an entire program, medication pooling offers a pathway to cost-effective and sustainable clinical trial management.

• Productivity Hacks For An Effective RFP / Clinical Trial Vendor Selection

  Starting a new clinical study requires careful vendor selection and these practical, actionable steps to enhance your selection process and ensure long-term partnership alignment.

• Taking Advantage Of EMA CTR For eCOA Studies In EU

  Discover how sponsors can save time and effort by applying for clinical trial authorization once across the EU using the Clinical Trials Information System (CTIS).

• Modern Post-Market Trials Driven By RWD – Is Your EDC Ready?

  Explore the transformative role of real-world data (RWD) and advanced Electronic Data Capture (EDC) systems in post-market research, marking a departure from traditional Phase IV trials.

• What AI Replaces In Phase 2/3 Data Management

  Explore how clinical teams are moving beyond AI hype to implement grounded strategies for automated edit checks, risk-based query management, and the regulatory frameworks needed for oversight.

• IRT vs. RTSM: What Sponsors Need To Know When Choosing Clinical Trial Technology

  Mastering the nuances between IRT and RTSM allows trial teams to move past confusing jargon and focus on the supply intelligence and randomization logic essential for study integrity.